IP Library Granted Patent US 11,534,421
Granted Patent B2
US 11,534,421 · App. 16/625,505 · Granted Dec 27, 2022

Cannabinoid pouch

Inventor: Heidi Ziegler Bruun (Vejle Ost, DK)
A61K31/353A61K9/009A61K31/05A61K47/02A61K47/12A61K47/26
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,534,421
App. No.
16/625,505
Granted
Dec 27, 2022
Kind
B2
Abstract

A pouch designed for administration of an active ingredient in the oral cavity is disclosed, the pouch containing a matrix composition having a combination of an amount of one or more cannabinoids and a water-insoluble composition. Also, pouches for use as a medicament, for use in alleviation of pain, and for use in mitigation of appetite deficiency are disclosed. Further, a method of alleviation of pain and a method of mitigation of appetite deficiency using the pouch are disclosed.

Claims (32)

1. A pouch designed for administration of an active ingredient in the oral cavity, the pouch containing a matrix composition comprising:

powdered granules comprising a combination of

an amount of one or more cannabinoids; and

a water-insoluble composition comprising microcrystalline cellulose (MCC), wherein the matrix composition further comprises a water-soluble composition comprising one or more sugar alcohols, and wherein the pouch comprises a water-permeable membrane.

2. The pouch according to claim 1 , wherein the matrix composition comprises said water-insoluble composition in an amount of between 1 and 80 percent by weight of said matrix composition.

3. The pouch according to claim 1 , wherein the water-insoluble composition further comprises an ion-exchange resin.

4. The pouch according to claim 3 , wherein the ion-exchange resin is present in an amount of 5 to 60 percent of said matrix composition.

5. The pouch according to claim 1 , wherein the matrix composition further comprises a release controlling composition.

6. The pouch according to claim 5 , wherein said release controlling composition is hydrophobic.

7. The pouch according to claim 5 wherein said release controlling composition comprises one or more metallic stearates.

8. The pouch according to claim 5 , wherein the matrix composition comprises said release controlling composition in an amount of between 1 and 20 percent by weight of said matrix composition.

9. The pouch according to claim 1 , wherein the one or more cannabinoids is physically or chemically bound to at least a part of the matrix composition acting as a carrier.

10. The pouch according to claim 1 , wherein the one or more cannabinoids comprises cannabidiol.

11. The pouch according to claim 1 , wherein the one or more cannabinoids comprises tetrahydrocannabinol.

12. The pouch according to claim 1 , wherein the pouch further comprises a humectant.

13. A pouch designed for administration of an active ingredient in the oral cavity, the pouch containing a matrix composition comprising:

a powder composition comprising

an amount of one or more cannabinoids;

a water-soluble composition comprising one or more sugar alcohols; and

a water-insoluble composition comprising microcrystalline cellulose (MCC), wherein the pouch comprises a water-permeable membrane.

14. A pouch designed for administration of an active ingredient in the oral cavity, the pouch containing a powdered matrix composition comprising:

an amount of one or more cannabinoids;

a water-soluble composition comprising one or more sugar alcohols; and

a water-insoluble composition comprising microcrystalline cellulose (MCC), wherein the one or more cannabinoids is physically or chemically bound to at least a part of the powdered matrix composition acting as a carrier, and wherein the pouch comprises a water-permeable membrane.

15. The pouch according to claim 13 , wherein the water-permeable membrane is a woven fabric.

16. The pouch according to claim 13 , wherein the water-permeable membrane is a non-woven fabric.

17. The pouch according to claim 13 , wherein the matrix composition comprises said one or more cannabinoids in an amount of 0.25 to 500 milligrams.

18. The pouch according to claim 13 , wherein the one or more cannabinoids is physically or chemically bound to at least a part of the matrix composition acting as a carrier.

19. The pouch according to claim 13 , wherein the matrix composition comprises said water-insoluble composition in an amount of between 1 and 80 percent by weight of said matrix composition.

20. The pouch according to claim 14 , wherein the one or more cannabinoids comprises cannabidiol and/or tetrahydrocannabinol.

21. The pouch according to claim 14 , wherein the pouch further comprises a humectant.

22. The pouch according to claim 14 , wherein the powdered matrix composition has an average particle size between 1 and 1200 micrometers.

Assignments (3)
CHANGE OF NAME Recorded Oct 1, 2020
From: MEDCAN PHARMA A/S
To: NORDICCAN A/S
Reel/Frame 053967/0932 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 28, 2020
From: FERTIN PHARMA A/S
To: MEDCAN PHARMA A/S
Reel/Frame 052509/0054 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 16, 2020
From: BRUUN, HEIDI ZIEGLER
To: FERTIN PHARMA A/S
Reel/Frame 052415/0836 →
Continuity (1)
Related Publication 20210023046A1 · Jan 28, 2021
Cited By (1)
US 12,263,241